Showing results (1921-1930 of 1,999) with videos related to

Sort By:
Pageof 200
JTO Clinical and Research Reports|September 30, 2021
Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLCBiagio Ricciuti, Abdul Rafeh Naqash, Jarushka Naidoo, et al.
Acta Tropica|May 2, 2013
Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: early impact and preliminary dataEdmundo Larrieu, Eduardo Herrero, Guillermo Mujica, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2024
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancerA Di Federico, S L Alden, J W Smithy, et al.
Mbio|September 30, 2020
Host Retromer Protein Sorting Nexin 2 Interacts with Human Respiratory Syncytial Virus Structural Proteins and is Required for Efficient Viral ProductionRicardo S Cardoso, Lucas Alves Tavares, Bruna Lais S Jesus, et al.
Journal of Virology|March 18, 2016
The Large Marseillevirus Explores Different Entry Pathways by Forming Giant Infectious VesiclesThalita Souza Arantes, Rodrigo Araújo Lima Rodrigues, Ludmila Karen Dos Santos Silva, et al.
Frontiers in Microbiology|August 15, 2022
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern ItalyCarmela De Marco, Claudia Veneziano, Alice Massacci, et al.
Therapeutic Advances in Musculoskeletal Disease|July 2, 2026
Mapping emotional function in fibromyalgia: integrating alexithymia, pain catastrophizing, and self-compassionFrancesca Trunfio, Onorina Berardicurti, Rosa Bruni, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort studyArielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti, et al.
The Oncologist|August 17, 2023
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung CancerArielle Elkrief, Biagio Riccuiti, Joao V Alessi, et al.
Nature Cardiovascular Research|August 28, 2024
An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injurySharon Fleischer, Trevor R Nash, Manuel A Tamargo, et al.
Pageof 200